BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29425137)

  • 1. Structure-Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase.
    Zhou LY; Peng JL; Wang JM; Geng YY; Zuo ZL; Hua Y
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29425137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.
    Zheng X; Zhou S; Zhang C; Wu D; Luo HB; Wu Y
    J Mol Model; 2017 Aug; 23(9):272. PubMed ID: 28861624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on xanthones from aerial parts of Polygala sibirica].
    Song Y; Jiang Y; Zhou S; Bi D; Tu P
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):574-6. PubMed ID: 19526786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors.
    Malik N; Dhiman P; Khatkar A
    Curr Top Med Chem; 2019; 19(2):123-138. PubMed ID: 30727896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.
    Hu L; Hu H; Wu W; Chai X; Luo J; Wu Q
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4013-5. PubMed ID: 21620698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of Novel Xanthine Oxidase Inhibitors Based on 1,6-Dihydropyrimidine-5-Carboxylic Acids by an Integrated in Silico Study.
    Zhai N; Wang C; Wu F; Xiong L; Luo X; Ju X; Liu G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
    Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation.
    Yan J; Zhang G; Hu Y; Ma Y
    Food Chem; 2013 Dec; 141(4):3766-73. PubMed ID: 23993547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action mechanisms and interaction of two key xanthine oxidase inhibitors in galangal: Combination of in vitro and in silico molecular docking studies.
    Ou R; Lin L; Zhao M; Xie Z
    Int J Biol Macromol; 2020 Nov; 162():1526-1535. PubMed ID: 32777423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
    Liu G; Wang W; Wan Y; Ju X; Gu S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two New Flavonol Glycosides from Polygala sibirica L. var megalopha Fr.
    Huang YJ; Zhou LY; Wang JM; Li Q; Geng YY; Liu HY; Hua Y
    Molecules; 2015 Dec; 20(12):21494-500. PubMed ID: 26633343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
    Xu HR; Fu L; Zhan P; Liu XY
    SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.